R R Deterding

Summary

Affiliation: University of Colorado
Country: USA

Publications

  1. ncbi Safety and tolerability of denufosol tetrasodium inhalation solution, a novel P2Y2 receptor agonist: results of a phase 1/phase 2 multicenter study in mild to moderate cystic fibrosis
    Robin Deterding
    Department of Pediatrics, Children s Hospital, Denver, Colorado 80218, USA
    Pediatr Pulmonol 39:339-48. 2005
  2. ncbi Persistent tachypnea of infancy is associated with neuroendocrine cell hyperplasia
    Robin R Deterding
    Pediatric Pulmonary Section, Department of Pediatrics, University of Colorado Health Science Center, Children s Hospital, Denver, Colorado 80218, USA
    Pediatr Pulmonol 40:157-65. 2005
  3. ncbi How to evaluate and treat children's interstitial lung disease
    Robin Deterding
    Department of Pediatrics, University of Colorado Health Science Center, The Children's Hospital, Campus Box B395, 1056 E. 19th Avenue, Denver, CO 80218, USA
    Paediatr Respir Rev 7:S245-7. 2006
  4. ncbi The new University of Colorado medical school curriculum: a pediatric perspective
    Robin R Deterding
    University of Colorado School of Medicine, Denver, Colorado, USA
    J Pediatr 151:S32-6. 2007
  5. ncbi Phase 2 randomized safety and efficacy trial of nebulized denufosol tetrasodium in cystic fibrosis
    Robin R Deterding
    The Children s Hospital, 1056 East 19th Avenue, B395, Denver, CO 80218, USA
    Am J Respir Crit Care Med 176:362-9. 2007
  6. ncbi Evaluating infants and children with interstitial lung disease
    Robin Deterding
    Department of Pediatrics, University of Colorado, School of Medicine, The Children s Hospital, Denver Colorado 80218, USA
    Semin Respir Crit Care Med 28:333-41. 2007
  7. ncbi Familial neuroendocrine cell hyperplasia of infancy
    J Popler
    Department of Pediatrics, University of Colorado Denver, Aurora, CO 80045, USA
    Pediatr Pulmonol 45:749-55. 2010
  8. ncbi Serum KL-6 differentiates neuroendocrine cell hyperplasia of infancy from the inborn errors of surfactant metabolism
    M L Doan
    Pediatric Pulmonary Section, Department of Pediatrics, Baylor College of Medicine, Texas Children s Hospital, 6621 Fannin, Houston, TX 77030, USA
    Thorax 64:677-81. 2009
  9. ncbi Molecular identification of bacteria in bronchoalveolar lavage fluid from children with cystic fibrosis
    J Kirk Harris
    Department of Molecular, Cellular, and Developmental Biology, University of Colorado, Boulder, CO 80309, USA
    Proc Natl Acad Sci U S A 104:20529-33. 2007
  10. ncbi A case study of teaching presence in virtual problem-based learning groups
    Carol S Kamin
    University of Colorado School of Medicine, Denver, CO, USA
    Med Teach 28:425-8. 2006

Research Grants

  1. Pediatric Interstitial Lung Disease Conference
    Robin Deterding; Fiscal Year: 2004

Collaborators

Detail Information

Publications13

  1. ncbi Safety and tolerability of denufosol tetrasodium inhalation solution, a novel P2Y2 receptor agonist: results of a phase 1/phase 2 multicenter study in mild to moderate cystic fibrosis
    Robin Deterding
    Department of Pediatrics, Children s Hospital, Denver, Colorado 80218, USA
    Pediatr Pulmonol 39:339-48. 2005
    ..recently completed a multicenter, 28-day, phase 2 safety and efficacy clinical trial of denufosol inhalation solution in CF subjects with mild lung disease...
  2. ncbi Persistent tachypnea of infancy is associated with neuroendocrine cell hyperplasia
    Robin R Deterding
    Pediatric Pulmonary Section, Department of Pediatrics, University of Colorado Health Science Center, Children s Hospital, Denver, Colorado 80218, USA
    Pediatr Pulmonol 40:157-65. 2005
    ..These findings may be important for the evaluation of ILD in young children...
  3. ncbi How to evaluate and treat children's interstitial lung disease
    Robin Deterding
    Department of Pediatrics, University of Colorado Health Science Center, The Children's Hospital, Campus Box B395, 1056 E. 19th Avenue, Denver, CO 80218, USA
    Paediatr Respir Rev 7:S245-7. 2006
  4. ncbi The new University of Colorado medical school curriculum: a pediatric perspective
    Robin R Deterding
    University of Colorado School of Medicine, Denver, Colorado, USA
    J Pediatr 151:S32-6. 2007
    ..We hope that sharing our experience, may benefit others in medical education...
  5. ncbi Phase 2 randomized safety and efficacy trial of nebulized denufosol tetrasodium in cystic fibrosis
    Robin R Deterding
    The Children s Hospital, 1056 East 19th Avenue, B395, Denver, CO 80218, USA
    Am J Respir Crit Care Med 176:362-9. 2007
    ....
  6. ncbi Evaluating infants and children with interstitial lung disease
    Robin Deterding
    Department of Pediatrics, University of Colorado, School of Medicine, The Children s Hospital, Denver Colorado 80218, USA
    Semin Respir Crit Care Med 28:333-41. 2007
    ..Diagnostic techniques have also evolved to provide more advanced testing in children. This article reviews the current evaluation for children with ILD and highlights areas of controversy...
  7. ncbi Familial neuroendocrine cell hyperplasia of infancy
    J Popler
    Department of Pediatrics, University of Colorado Denver, Aurora, CO 80045, USA
    Pediatr Pulmonol 45:749-55. 2010
    ..Lung histology shows hyperplasia of bombesin-immunopositive neuroendocrine cells within distal bronchioles and alveolar ducts without other identifiable lung pathology or developmental anomaly...
  8. ncbi Serum KL-6 differentiates neuroendocrine cell hyperplasia of infancy from the inborn errors of surfactant metabolism
    M L Doan
    Pediatric Pulmonary Section, Department of Pediatrics, Baylor College of Medicine, Texas Children s Hospital, 6621 Fannin, Houston, TX 77030, USA
    Thorax 64:677-81. 2009
    ....
  9. ncbi Molecular identification of bacteria in bronchoalveolar lavage fluid from children with cystic fibrosis
    J Kirk Harris
    Department of Molecular, Cellular, and Developmental Biology, University of Colorado, Boulder, CO 80309, USA
    Proc Natl Acad Sci U S A 104:20529-33. 2007
    ..These results show that molecular techniques provide a broader perspective on airway bacteria than do routine clinical cultures and thus can identify targets for further clinical evaluation...
  10. ncbi A case study of teaching presence in virtual problem-based learning groups
    Carol S Kamin
    University of Colorado School of Medicine, Denver, CO, USA
    Med Teach 28:425-8. 2006
    ..Facilitating discourse and direct instruction were comparable, 19.5(SD = 7.4) and 19.5 (SD = 6.7), respectively. Messages and indicators of teacher presence rose across time with a decline during subsequent PBL cases with the same group...
  11. ncbi Pediatric interstitial lung disease revisited
    Leland L Fan
    Pediatric Pulmonary Section, Department of Pediatrics, Baylor College of Medicine, Texas Children s Hospital, Houston 77030 2399, USA
    Pediatr Pulmonol 38:369-78. 2004
    ..Most often, lung biopsy is required. Current treatment options remain less than satisfactory, and morbidity and mortality remain considerable...
  12. ncbi Lessons learned in modeling virtual pediatric patients
    Robert C Hubal
    RTI International, Technology Assisted Learning Division, Research Triangle Park, NC, USA
    Stud Health Technol Inform 94:127-30. 2003
    ..Both applications rely on existing responsive virtual human technology. The authors are engaged in preliminary clinical trials for the work described in this paper...
  13. ncbi Diaphragmatic hernia simulating a left pleural effusion
    Jamie L Wooldridge
    Department of Pediatrics, Children s Hospital, Denver, Colorado, USA
    Pediatrics 112:e487. 2003
    ..We also characterize the atypical chest radiographic findings of this patient and recommend further imaging with computed tomography in unusual patient presentations...

Research Grants1

  1. Pediatric Interstitial Lung Disease Conference
    Robin Deterding; Fiscal Year: 2004
    ..Communication between clinical and basic scientists and an enhanced interest in PILD will certainly occur. Ultimately the care of children with these rare diseases will be improved and the field advanced. ..